Maxcyte (MXCT) Cash from Investing Activities (2020 - 2026)

Maxcyte (MXCT) has 7 years of Cash from Investing Activities data on file, last reported at $2.7 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 72.13% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.1 million (down 38.22% YoY) and the FY2025 annual result came in at $25.9 million, up 274.13% from the prior year.
• Cash from Investing Activities slipped to $2.7 million in Q1 2026 per MXCT's latest filing, from $9.7 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $194.8 million in Q1 2022 and bottomed at -$131.9 million in Q2 2022.
• The 5-year median for Cash from Investing Activities is $2.8 million (2023), against an average of $3.9 million.
• Peak annual rise in Cash from Investing Activities reached 1141.41% in 2022, while the deepest fall reached 257.12% in 2022.
• Tracing MXCT's Cash from Investing Activities over 5 years: stood at -$27.1 million in 2022, then soared by 84.72% to -$4.1 million in 2023, then surged by 59.77% to -$1.7 million in 2024, then jumped by 681.14% to $9.7 million in 2025, then tumbled by 72.55% to $2.7 million in 2026.
• Per Business Quant, the three latest MXCT Cash from Investing Activities figures stand at $2.7 million (Q1 2026), $9.7 million (Q4 2025), and $5.2 million (Q3 2025).

Peer Comparison